Wird geladen...

Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient Care

BACKGROUND: Alemtuzumab is a monoclonal antibody that has been approved for the treatment of relapsing-remitting multiple sclerosis (MS). Alemtuzumab is associated with infusion reactions and potential autoimmune complications. Patient education and understanding are crucial to favorable outcomes. O...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J MS Care
Hauptverfasser: Rath, Louise, Vijiaratnam, Nirosen, Skibina, Olga
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Consortium of Multiple Sclerosis Centers 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5734716/
https://ncbi.nlm.nih.gov/pubmed/29270090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2017-010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!